A Breast Support Intervention for Women With Breast Pain

NCT ID: NCT02515253

Last Updated: 2019-09-09

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

33 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-10-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to assess whether prescribing a bra to participants results in an improvement in the Patient Global Impression of Change (PGIC) compared to participants who receive standard care alone.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mastodynia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Prescription group

Participants in this group will receive the standard care for benign breast pain sufferers (administered by the Queen Alexandra Hospital in Portsmouth) and will also attend the Department of Sport and Exercise Science at the University of Portsmouth for an individual bra prescription. Participants will be prescribed an appropriate bra to wear over an eight week intervention period.

Group Type EXPERIMENTAL

Bra prescription

Intervention Type OTHER

Standard Care

Intervention Type OTHER

Standard care group

Participants in this group will receive the standard care for benign breast pain sufferers administered by the Queen Alexandra Hospital in Portsmouth.

Group Type OTHER

Standard Care

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Bra prescription

Intervention Type OTHER

Standard Care

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Female, aged 18 years of age and above.
* Experiencing breast pain of any severity.
* Participants must be able to speak and read English fluently
* Participants must be a resident within the local area and not planning to move out of the area within the study timeline
* Participant must have attended the Queen Alexandra (QA) hospital for an assessment of their breast pain.
* Participant is willing and able to give informed consent for participation in the study.
* Participant is self-reported to be between a 34 and 40 under band size and a DD to G bra cup size.
* Able to walk on a treadmill for up to two minutes unaided and be able to walk unaided up and down a small set of steps (assessed verbally by the clinicians at QA hospital)
* Participants must be able to comply with the study procedures

Exclusion Criteria

* Participants are receiving any additional treatment for their breast pain that is not part of standard care (recommendation for a bra fit, topical ibuprofen, breast pain leaflet) including any cancer treatment
* Participants have had any surgery to the breasts within the last year
* Participants are currently pregnant or have been pregnant or breast fed in the past year
* Planning to undertake any activities or lifestyle changes which may affect their levels of breast pain e.g. trying for a baby, changing oral contraceptive, having breast surgery.
* Participant's data will be excluded from the analysis if they do not complete either survey at four or eight weeks (at least one follow up survey needs to be completed).
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Portsmouth Hospitals NHS Trust

OTHER_GOV

Sponsor Role collaborator

University of Portsmouth

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Emma Burnett

PhD Research Student

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emma Burnett, MRes

Role: PRINCIPAL_INVESTIGATOR

University of Portsmouth

Joanna Scurr, PhD

Role: STUDY_CHAIR

University of Portsmouth

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Sport and Exercise Science, University of Portsmouth

Portsmouth, , United Kingdom

Site Status

Breast Care Services, Queen Alexandra Hospital

Portsmouth, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BP-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.